#coinfection

Such generic drugs could save nations huge sums in the coming years.

People who are living with both HIV and hepatitis C virus (HCV) have a higher risk of developing non-AIDS-defining cancers.

Gloria Searson has been fighting to end the epidemic in New York City for almost 25 years.

MAO turns 30.

Two new studies presented at IAS 2017 shed more light on how our daily habits may affect liver disease risk.

A look at a large cohort of Canadians with HIV and hepatitis C also examined modifiable factors associated with a reduced risk of death.

At first, Jerome Adams was reluctant to support needle exchange programs. Now he champions them.

A clinic in Baltimore showed great success in eradicating hep C among a traditionally challenging population.

Millions of Americans have chronic hepatitis virus—a leading cause of liver cancer—and don’t even know it.

A major academic center found only two cases of on-the-job infections via cuts in a 13-year period.

Researchers analyzed data from a cohort to understand what factors help predict whether someone with HCV will later contract HIV.

Highlights from research presented at the 52nd International Liver Congress in Amsterdam

The risk appears higher among those more recently infected with HIV and those with a higher HIV viral load.

Real-world data showed Merck’s hep C regimen performed well among a population with genotypes 1 or 4 and multiple other health conditions.

Both those with and without compensated cirrhosis saw high hep C cure rates in a recent trial.

The prevalence of each virus is up to three times higher among homeless versus non-homeless veterans.